针对癌症免疫治疗的T细胞抗原的景观
Aviyah Peri1, Nadja Salomon2, Yochai Wolf3,4
1Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Nature cancer
|July 6, 2023
概括
免疫疗法利用T细胞通过识别瘤抗原来对抗癌症. 本综述比较了不同的癌症抗原,以获得有效和安全的临床治疗方法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 免疫疗法在治疗转移性癌症方面表现有前途,因为它使T细胞能够识别瘤抗原.
- 检查点阻塞疗法有局限性,突出了针对瘤抗原的替代策略的需要.
- 瘤抗原领域正在迅速扩大,新的类别正在出现.
研究的目的:
- 审查已知的癌症抗原及其特征.
- 分析与各种瘤抗原相关的现有临床数据.
- 为了比较不同抗原在引起临床反应方面的疗效和安全性.
主要方法:
- 关于癌症抗原的已发表研究的文献综述.
- 对与基于瘤抗原的治疗相关的临床试验数据的分析.
- 对抗原属性和临床结果的比较评估.
主要成果:
- 越来越多的癌症抗原被确定并被探索治疗潜力.
- 关于不同抗原的疗效和安全性的临床数据正在积累,但需要进一步合成.
- 对抗原特异性临床反应的直接比较是有限的.
结论:
- 了解各种癌症抗原的比较属性对于优化免疫治疗至关重要.
- 需要进一步的研究来阐明不同抗原如何影响治疗效率和安全性.
- 利用多种瘤抗原为补充性癌症治疗提供了一个有希望的途径.
更多相关视频
相关概念视频
Tumor Immunotherapy
573
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
573
Cancer Vaccines
428
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
428
T Cell Activation and Clonal Selection
832
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
832
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Antigens Involved in Adaptive Immunity
560
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
560


